Keyword: Medicare Payment Advisory Commission (MedPAC)
Part D drug spending continues to rise, and a government watchdog argues giving plan sponsors strong incentives to negotiate prices is a key solution.
Medicare Part D was launched before the rapid rise of pricey specialty drugs, so MedPAC is weighing a significant overhaul of the program.
MedPAC voted to approve a set of recommendations aimed at boosting the accuracy of Medicare Advantage encounter data.
MedPAC commissioners weighed what a Medicare without fee-for-service might look like at a meeting Thursday.
MedPAC warns in its March report to Congress that current Part D policy may encourage health plans to shirk responsibility for managing spending.
Post-acute care may not be the optimal space for bundled payments—at least not yet, MedPAC commissioners said Friday.
The Medicare Payment Advisory Commission is weighing reference pricing and binding arbitration as possible solutions for rising drug prices in Part B.
An Orlando-area orthopedic surgeon was part of an agreement to pay $1.5 million to resolve allegations of an illegal kickback scheme.
MedPAC issued draft policy recommendations on Friday aimed at controlling drug costs in Medicare Parts B and D.
MedPAC on Thursday voted to approve a recommendation that Congress and CMS overhaul quality and value programs for hospitals.